Investments
64Portfolio Exits
16Funds
2About Emergent Medical Partners
Emergent Medical Partners, founded in 2007, is a life sciences investment firm that focuses on seed and early stage investments. Its focus is on early stage companies and our expertise encompasses all areas of medicine, including cardiovascular and general surgery, orthopedic surgery, cardiology, radiology, oncology, obesity, gynecology, oncology, and sleep disorders.
Want to inform investors similar to Emergent Medical Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Emergent Medical Partners News
Jun 1, 2021
Standard Bariatrics, Inc. , a Cincinnati, OH-based bariatric surgery medical device company, raised $35M in Series B funding. The round was led by U.S. Venture Partners (USVP) with participation from new investor River Cities Capital, RiverVest® Venture Partners, Hatteras Venture Partners, Queen City Angels and Emergent Medical Partners. Led by CEO Matt Sokany, Standard Bariatrics has developed the Titan SGS™, a design that offers surgeons performing sleeve gastrectomy, a bariatric surgical procedure for obesity disease. In April of 2021, the company’s Titan SGS™ stapler received clearance from the US Food and Drug Administration allowing the device to be used in bariatric surgery requiring the creation of sleeve pouch anatomy (sleeve gastrectomy). The submission was supported by the completion of a successful 62-patient study. FinSMEs 01/06/2021
Emergent Medical Partners Investments
64 Investments
Emergent Medical Partners has made 64 investments. Their latest investment was in Standard Bariatrics as part of their Series B on June 6, 2021.
Emergent Medical Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/1/2021 | Series B | Standard Bariatrics | $35M | No | 8 | |
3/16/2021 | Series B - II | BioTrace Medical | $10.87M | No | Emergent Medical Partners, and Undisclosed Investors | 1 |
5/6/2020 | Series C | Arterys | $28M | No | 2 | |
3/19/2020 | Series E | |||||
8/27/2019 | Debt |
Date | 6/1/2021 | 3/16/2021 | 5/6/2020 | 3/19/2020 | 8/27/2019 |
|---|---|---|---|---|---|
Round | Series B | Series B - II | Series C | Series E | Debt |
Company | Standard Bariatrics | BioTrace Medical | Arterys | ||
Amount | $35M | $10.87M | $28M | ||
New? | No | No | No | ||
Co-Investors | Emergent Medical Partners, and Undisclosed Investors | ||||
Sources | 8 | 1 | 2 |
Emergent Medical Partners Portfolio Exits
16 Portfolio Exits
Emergent Medical Partners has 16 portfolio exits. Their latest portfolio exit was Relievant Medsystems on September 19, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/19/2023 | Acquired | 6 | |||
8/22/2022 | Acquired | 16 | |||
11/24/2021 | IPO | Public | 2 | ||
Date | 9/19/2023 | 8/22/2022 | 11/24/2021 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 6 | 16 | 2 |
Emergent Medical Partners Fund History
2 Fund Histories
Emergent Medical Partners has 2 funds, including Emergent Medical Partners II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
9/10/2014 | Emergent Medical Partners II | Early-Stage Venture Capital | Closed | $60.15M | 1 |
3/1/2012 | Emergent Medical Partners I |
Closing Date | 9/10/2014 | 3/1/2012 |
|---|---|---|
Fund | Emergent Medical Partners II | Emergent Medical Partners I |
Fund Type | Early-Stage Venture Capital | |
Status | Closed | |
Amount | $60.15M | |
Sources | 1 |
Emergent Medical Partners Team
4 Team Members
Emergent Medical Partners has 4 team members, including current Managing Director, Bob Brownell.
Name | Work History | Title | Status |
|---|---|---|---|
Bob Brownell | Managing Director | Current | |
Name | Bob Brownell | |||
|---|---|---|---|---|
Work History | ||||
Title | Managing Director | |||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
